Brief: Integra Lifesciences Q2 Adjusted EPS USD 0.71 Vs. IBES Estimate USD 0.57
26/07/2023 23:30
Jul 26 (Reuters) - Integra Lifesciences Q2 adjusted net income USD 57.4 million. * Q2 adjusted EBITDA USD 88.8 million * Q2 adjusted gross margin 67.6% * Q2 revenue USD 381.3 million vs. IBES estimate USD 374.1 million * Q2 EPS USD 0.05
Recent news on Integra LifeSciences Holdings
See all newsIntegra LifeSciences Holdings Corporation reports results for the quarter ended September 30 - Earnings Summary
Integra Lifesciences Q3 revenue slightly misses estimates on flood damage
Brief: Integra Lifesciences - Enters Amended And Restated Credit Agreement On Oct 19, 2026 - SEC Filing
Brief: Integra Announces Completion Of Refinancing Transactions
Brief: Integra Announces Pricing Of Senior Secured Notes